102 related articles for article (PubMed ID: 3488022)
1. In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.
Elwell LP; Wilson HR; Knick VB; Keith BR
Antimicrob Agents Chemother; 1986 Jun; 29(6):1092-4. PubMed ID: 3488022
[TBL] [Abstract][Full Text] [Related]
2. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
3. A decade of antimicrobial resistance in Staphylococcus aureus: A single center experience.
Vicetti Miguel CP; Mejias A; Leber A; Sanchez PJ
PLoS One; 2019; 14(2):e0212029. PubMed ID: 30753206
[TBL] [Abstract][Full Text] [Related]
4. Impact of the combination of daptomycin and trimethoprim-sulfamethoxazole on clinical outcomes in methicillin-resistant Staphylococcus aureus infections.
Claeys KC; Smith JR; Casapao AM; Mynatt RP; Avery L; Shroff A; Yamamura D; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2015 Apr; 59(4):1969-76. PubMed ID: 25605354
[TBL] [Abstract][Full Text] [Related]
5. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
[TBL] [Abstract][Full Text] [Related]
6. Increasing Clindamycin and Trimethoprim-Sulfamethoxazole Resistance in Pediatric Staphylococcus aureus Infections.
Khamash DF; Voskertchian A; Tamma PD; Akinboyo IC; Carroll KC; Milstone AM
J Pediatric Infect Dis Soc; 2019 Sep; 8(4):351-353. PubMed ID: 30011009
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the novel combination of high-dose daptomycin plus trimethoprim-sulfamethoxazole against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus using an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.
Steed ME; Werth BJ; Ireland CE; Rybak MJ
Antimicrob Agents Chemother; 2012 Nov; 56(11):5709-14. PubMed ID: 22908167
[TBL] [Abstract][Full Text] [Related]
8. Influence of ionizing radiation on the antimicrobial activity of the antibiotics sulfamethoxazole and trimethoprim.
Sági G; Szabacsi K; Szabó L; Homlok R; Kovács K; Mohácsi-Farkas C; Pillai SD; Takács E; Wojnárovits L
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2018 Jul; 53(8):687-693. PubMed ID: 29485359
[TBL] [Abstract][Full Text] [Related]
9. Screening method for trimethoprim/sulfamethoxazole-resistant small colony variants of Staphylococcus aureus.
Sato T; Kawamura M; Furukawa E; Fujimura S
J Glob Antimicrob Resist; 2018 Dec; 15():1-5. PubMed ID: 29857058
[TBL] [Abstract][Full Text] [Related]
10. Halogenated trimethoprim derivatives as multidrug-resistant Staphylococcus aureus therapeutics.
Nilchan N; Phetsang W; Nowwarat T; Chaturongakul S; Jiarpinitnun C
Bioorg Med Chem; 2018 Oct; 26(19):5343-5348. PubMed ID: 29784273
[TBL] [Abstract][Full Text] [Related]
11. The use of trimethoprim and sulfamethoxazole (TMP-SMX) in dermatology.
Michałek K; Lechowicz M; Pastuszczak M; Wojas-Pelc A
Folia Med Cracov; 2015; 55(1):35-41. PubMed ID: 26774630
[TBL] [Abstract][Full Text] [Related]
12. The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis.
Vilchèze C; Jacobs WR
Antimicrob Agents Chemother; 2012 Oct; 56(10):5142-8. PubMed ID: 22825115
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review.
Chang VS; Dhaliwal DK; Raju L; Kowalski RP
Cornea; 2015 Jun; 34(6):698-703. PubMed ID: 25811722
[TBL] [Abstract][Full Text] [Related]
14. Has the emergence of community-associated methicillin-resistant Staphylococcus aureus increased trimethoprim-sulfamethoxazole use and resistance?: a 10-year time series analysis.
Wood JB; Smith DB; Baker EH; Brecher SM; Gupta K
Antimicrob Agents Chemother; 2012 Nov; 56(11):5655-60. PubMed ID: 22908161
[TBL] [Abstract][Full Text] [Related]
15. Emergence of trimethoprim resistance gene dfrG in Staphylococcus aureus causing human infection and colonization in sub-Saharan Africa and its import to Europe.
Nurjadi D; Olalekan AO; Layer F; Shittu AO; Alabi A; Ghebremedhin B; Schaumburg F; Hofmann-Eifler J; Van Genderen PJ; Caumes E; Fleck R; Mockenhaupt FP; Herrmann M; Kern WV; Abdulla S; Grobusch MP; Kremsner PG; Wolz C; Zanger P
J Antimicrob Chemother; 2014 Sep; 69(9):2361-8. PubMed ID: 24855123
[TBL] [Abstract][Full Text] [Related]
16. Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children.
Autmizguine J; Melloni C; Hornik CP; Dallefeld S; Harper B; Yogev R; Sullivan JE; Atz AM; Al-Uzri A; Mendley S; Poindexter B; Mitchell J; Lewandowski A; Delmore P; Cohen-Wolkowiez M; Gonzalez D;
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084742
[TBL] [Abstract][Full Text] [Related]
17. Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus.
Cadena J; Nair S; Henao-Martinez AF; Jorgensen JH; Patterson JE; Sreeramoju PV
Antimicrob Agents Chemother; 2011 Dec; 55(12):5430-2. PubMed ID: 21930870
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic susceptibility profile and synergistic effect of non-steroidal anti-inflammatory drugs on antibacterial activity of resistant antibiotics (Oxytetracycline and Gentamicin) against methicillin resistant Staphylococcus aureus (MRSA).
Altaf M; Ijaz M; Ghaffar A; Rehman A; Avais M
Microb Pathog; 2019 Dec; 137():103755. PubMed ID: 31542423
[TBL] [Abstract][Full Text] [Related]
19.
Mohammadi-Berenjestanaki H; Khori V; Shirzad-Aski H; Ghaemi EA
Microb Drug Resist; 2020 Mar; 26(3):218-226. PubMed ID: 31424323
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.
El Haj C; Murillo O; Ribera A; Lloberas N; Gómez-Junyent J; Tubau F; Fontova P; Cabellos C; Ariza J
Int J Antimicrob Agents; 2018 Jun; 51(6):854-861. PubMed ID: 29374577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
